SLC6 Transporter Folding Diseases and Pharmacochaperoning
The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
The human genome encodes 19 genes of the solute carrier 6 (SLC6) family; non-synonymous changes in the coding sequence give rise to mutated transporters, which are misfolded and thus cause diseases in the affected individuals. Prominent examples include mutations in the transporters for dopamine (DAT, SLC6A3), for creatine (CT1, SLC6A8), and for glycine (GlyT2, SLC6A5), which result in infantile dystonia, mental retardation, and hyperekplexia, respectively. Thus, there is an obvious unmet medical need to identify compounds, which can remedy the folding deficit. The pharmacological correction of folding defects was originally explored in mutants of the serotonin transporter (SERT, SLC6A4), which were created to study the COPII-dependent export from the endoplasmic reticulum. This led to the serendipitous discovery of the pharmacochaperoning action of ibogaine. Ibogaine and its metabolite noribogaine also rescue several disease-relevant mutants of DAT. Because the pharmacology of DAT and SERT is exceptionally rich, it is not surprising that additional compounds have been identified, which rescue folding-deficient mutants. These compounds are not only of interest for restoring DAT function in the affected children. They are also likely to serve as useful tools to interrogate the folding trajectory of the transporter. This is likely to initiate a virtuous cycle: if the principles underlying folding of SLC6 transporters are understood, the design of pharmacochaperones ought to be facilitated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Low brain creatine content has been associated with muscle myopathies (e.g., weakness), voluntary or involuntary movement disorders that can affect muscle function and coordination, speech development, epilepsy, cognitive and motor development delays, and/or autism [53,61,203,204,206,207,208,209,210].”
From Creatine in health and disease (2021) · cites this paper as [204]
In the citing paper
“For this reason, high-dose, long-term creatine supplementation (e.g., 0.3–0.8 g/kg/day) throughout the lifespan is a nutritional strategy of increasing brain creatine content in these populations [53,61,203,204,206,207,208,209,210,211,212,213,214].”
From Creatine in health and disease (2021) · cites this paper as [204]
Citations
Cites
Principles that Govern the Folding of Protein Chains
Anfinsen, C. B. (1973) · Science · doi:10.1126/science.181.4096.223 · Cited by 7,096
Journal of Biological Chemistry
(2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,400
Statistical potential for assessment and prediction of protein structures
Shen, M., & Sali, A. (2006) · Protein Science · doi:10.1110/ps.062416606 · Cited by 2,307
The Protein-Folding Problem, 50 Years On
Dill, K. A., & MacCallum, J. L. (2012) · Science · doi:10.1126/science.1219021 · Cited by 1,699
Löscher, W. (2011) · Seizure · doi:10.1016/j.seizure.2011.01.003 · Cited by 932
X-ray structures and mechanism of the human serotonin transporter
Coleman, J. A., Green, E. M., & Gouaux, E. (2016) · Nature · doi:10.1038/nature17629 · Cited by 668
X-ray structure of dopamine transporter elucidates antidepressant mechanism
Penmatsa, A., Wang, K. H., & Gouaux, E. (2013) · Nature · doi:10.1038/nature12533 · Cited by 612
Dopamine Is a Regulator of Arousal in the Fruit Fly
Kume, K., Kume, S., Park, S. K., Hirsh, J., & Jackson, F. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2048-05.2005 · Cited by 597
Orthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency
Shannon, J. R., Flattem, N. L., Jordan, J., Jacob, G., Black, B. K., Biaggioni, I., Blakely, R. D., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420803 · Cited by 594
Enhanced tonic GABAA inhibition in typical absence epilepsy
Cope, D. W., Di Giovanni, G., Fyson, S. J., Orbán, G., Errington, A. C., Lőrincz, M. L., Gould, T. M., Carter, D. A., & Crunelli, V. (2009) · Nature Medicine · doi:10.1038/nm.2058 · Cited by 431
Research works printed but not linked: 1
- Levinthal C (1969) How to fold graciously. In: DeBrunner JTP, Munck E (eds) Mössbauer spectroscopy in biological systems. University of Illinois Press, Allerton House, Monticello, IL, pp 22–24
Cited by
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Kasture, A. S., Hummel, T., Sučić, S., & Freissmuth, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061788 · Cited by 108
Self-citationA systematic literature review of clinical trials and therapeutic applications of ibogaine
Köck, P., Froelich, K., Walter, M., Lang, U. E., & Dürsteler, K. M. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108717 · Cited by 88
The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome
Farr, C. V., El‐Kasaby, A., Freissmuth, M., & Sučić, S. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.588954 · Cited by 58
Self-citationEl‐Kasaby, A., Kasture, A. S., Koban, F., Hoťka, M., Asjad, H. M. M., Kubista, H., Freissmuth, M., & Sučić, S. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.015 · Cited by 58
Self-citation
Metadata
- Authors
- Freissmuth, M., Stockner, T., & Sucic, S.
- Affiliations
- Medical University of Vienna (AT)
- Corresponding author
- Freissmuth, Michael
- Venue
- Handbook of experimental pharmacology
- Publisher
- Springer International Publishing
- Published
- 2017
- Volume
- 245
- Pages
- 249-270
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W2765579156
- Cited by
- 42
- References
- 90
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 1
- FWCI
- 4.08
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Handbook of experimental pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Keywords
- pharmacochaperone, protein folding defects, dopamine transporter, serotonin transporter, creatine transporter, glycine transporter, ibogaine, noribogaine, hyperekplexia, intellectual disability, endoplasmic reticulum
- MeSH terms
- Solute Carrier Proteins, Animals, Humans, Mutation, Protein Folding, Molecular Chaperones, Dopamine Plasma Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins, Drug Discovery, Proteostasis Deficiencies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SLC6 Transporter Folding Diseases and Pharmacochaperoning. https://app.cochat.ai/papers/10.1007/164_2017_71
- The paper
- Freissmuth, M., Stockner, T., & Sucic, S. (2017). SLC6 Transporter Folding Diseases and Pharmacochaperoning. Handbook of experimental pharmacology. https://doi.org/10.1007/164_2017_71
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.